retatrutide trial results today Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Michael Weintraub, MD on X:

The NICE criteria are as follows: NICE recommends GLP-1 analogues or Tirzepatide (Mounjaro) for the treatment of adults with type 2 diabetes alongside diet and exercise when diabetes is insufficiently controlled, only if: triple therapy with metformin and 2 other oral antidiabetic drugs is ineffective, not tolerated or contraindicated, and a person has a body mass index (BMI) of 35 kg/m2 or more, and specific psychological or other medical problems associated with obesity, or a person has a BMI of less than 35 kg/m2, and: Insulin therapy would have significant occupational implications, or Weight loss would benefit other significant obesity-related complications

The complete framework is set out on the batch verification page

is the founder of Real World Genetics OY

Research literature describes benzyl alcohol as an effective preservative used in appropriately formulated multidose products (Johnson et al., 2017)